검색
Tonix Pharmaceuticals Holding Corp
TNXP관심 목록에 추가
11.870USD
-0.410-3.34%
종가 09-11 16:00（ET）
198.99M시가총액
손실P/E TTM
자세한 내용은 Tonix Pharmaceuticals Holding Corp 회사
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.
Tonix Pharmaceuticals Holding Corp 프로필
종목 코드 TNXP
회사 이름Tonix Pharmaceuticals Holding Corp
상장일Mar 29, 2010
CEOLederman (Seth)
직원 수81
유형Ordinary Share
회계 연도 종료Mar 29
주소26 Main Street, Suite 101
도시CHATHAM
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호07928
전화12129809155
웹사이트https://www.tonixpharma.com/
종목 코드 TNXP
상장일Mar 29, 2010
CEOLederman (Seth)
Tonix Pharmaceuticals Holding Corp의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. James Treco
Mr. James Treco
Lead Independent Director
Lead Independent Director
250.00
--
Mr. James Treco
Mr. James Treco
Lead Independent Director
Lead Independent Director
250.00
--
Mr. James Treco
Mr. James Treco
Lead Independent Director
Lead Independent Director
250.00
--
Dr. Gregory M. (Greg) Sullivan, M.D.
Dr. Gregory M. (Greg) Sullivan, M.D.
Secretary
Secretary
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
자주 묻는 질문
Tonix Pharmaceuticals Holding Corp의 상위 5대 주주는 누구인가요?
Tonix Pharmaceuticals Holding Corp의 상위 5대 주주는 다음과 같습니다: Dr. Seth Lederman, M.D.
Tonix Pharmaceuticals Holding Corp(TNXP)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Tonix Pharmaceuticals Holding Corp의 주식을 보유한 기관은 총 177곳이며, 이들이 보유한 주식의 총 가치는 약 4.66M로 전체 발행 주식의 32.65%를 차지합니다. 이는 2025Q4 대비 2019652.00 증가한 수치입니다.